Hinge Health, Inc. (HNGE) Fair Value 2026

HNGE · Services-Computer Processing & Data Preparation ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.2 /10

32 fundamental signals · 13 models active

Value Trap Risk

— (—/100)

Quick Summary — As of 2026-07-15, Hinge Health, Inc. (HNGE) trades at $85.78, approximately 189% above CirclFi’s Bayesian DCF fair value of $29.67. QOC: 6.2/10. 13/13 models active.

Key Facts

Ticker
HNGE
Price
$85.78
Quality Score
6.2/10
Value Trap Risk
—/100
Models Active
13/13
Last Updated
Strength: 13 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is Hinge Health, Inc. (HNGE) Undervalued or Overvalued in 2026?

According to CirclFi’s 13-model valuation engine, Hinge Health, Inc. (HNGE) appears overvalued as of : the median of 13 independent fair value estimates is $12.42, 85.5% below the current price of $85.78. Estimates range from $2.05 to $57.21. HNGE scores 6.2/10 on fundamental quality and —/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Hinge Health, Inc. Stock in 2026? →

Valuation Matrix

13 Intrinsic Value Models vs. Current Price ($85.78)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
 $29.67 -65.4%
Earnings Power Value
Low Conviction
 $2.24 -97.4%
CUCE Ensemble
Low Conviction
 $17.02 -80.2%
First Chicago
Medium Conviction
 $12.42 -85.5%

Unlock the Full Matrix

Access 9 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 13 Models →

Cancel anytime · No contracts · Instant access

What Is Hinge Health, Inc. (HNGE) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Hinge Health, Inc.'s intrinsic value is estimated at $18.86. Trading at its current price of $85.78, the valuation engine raises significant caution: 13 of 13 models flag downside risk, projecting an average implied return of -78.0%. Model dispersion is worth noting: PWERM targets $57.21 (-33.3%), versus Sentiment SOTP at $2.05 (-97.6%). This +64.3% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About HNGE?

13 of 13 models are currently active for HNGE. All 13 active models suggest the stock trades above fair value. The Bayesian DCF estimates HNGE's intrinsic value at $29.67, implying -65.4% downside from the current price. See which stocks rank higher →

How Does HNGE Rank in Services-Computer Processing & Data Preparation?

Among 66 Services-Computer Processing & Data Preparation stocks, HNGE ranks #42 by Quality of Company score. CirclFi's QOC score of 6.2/10 evaluates 32 fundamental signals. A score of 6.2 indicates above-average quality.

See all Most Undervalued Services-Computer Processing & Data Preparation Stocks →

Hinge Health, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is HNGE a Value Trap?

The Value Trap algorithm is not active for HNGE. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

13 of 13 models are active for Hinge Health, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Hinge Health, Inc. earns a quality score of 6.2/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +64.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every HNGE valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across HNGE's 13 active models, average confidence is 28%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Hinge Health, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Services-Computer Processing & Data Preparation Stocks Should You Also Analyze?

8 related Services-Computer Processing & Data Preparation stocks with 13-model coverage

INODInnodata Inc.QOC 10.0IBEXIBEX LimitedQOC 10.0UPWKUpwork Inc.QOC 9.9CARGCarGurus, Inc.QOC 9.5TRAKReposiTrak, Inc.QOC 9.4RAMPLiveRamp Holdings, Inc.QOC 9.2RDDTReddit, Inc.QOC 9.0OOMAOoma, Inc.QOC 9.0

Read investment analysis: INOD · IBEX · UPWK · CARG · TRAK

See all Services-Computer Processing & Data Preparation stocks ranked →

Frequently Asked Questions About Hinge Health, Inc.

What is Hinge Health, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Hinge Health, Inc. (HNGE) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $29.67. The Quality of Company score is 6.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is HNGE overvalued or undervalued right now?

At $85.78, 0 of 13 active models suggest HNGE may be undervalued, while 13 indicate potential overvaluation. The median of all 13 fair value estimates is $12.42, 85.5% below the current price of $85.78 — a consensus view that HNGE is overvalued. The assessment depends on which methodology best fits Hinge Health, Inc.'s business model in Services-Computer Processing & Data Preparation.

What does a Quality of Company score of 6.2 mean for HNGE?

Hinge Health, Inc.'s QOC of 6.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on HNGE?

CirclFi analyzes HNGE with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 13 of 13 are active for this stock. Read the full methodology →

Is HNGE a value trap in 2026?

CirclFi's Value Trap algorithm does not have sufficient data for HNGE at this time. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 13-model valuation engine, Hinge Health, Inc. (HNGE) has a median fair value of $12.42 — 85.5% below the current price of $85.78 — as of 2026-07-15.” Source: circlfi.com/stock/HNGE/ · Methodology

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 13 mathematical frameworks give you clarity on HNGE.

Unlock All 13 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access